Telehealth during and beyond the COVID-19 Pandemic: Evidence from licensed dietitians in an emerging economy
PLOS One · 2026
DOI: 10.1371/journal.pone.0311330 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Maya Assaad und 3 weiteren Autor:innen. Beteiligte Einrichtung: Abu Dhabi School, Abu Dhabi School of Management, Abu Dhabi, United Arab Emirates. Hauptthemen laut MEDLINE: COVID-19, Telemedicine, Nutritionists. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Digitalisierung in der Pflege
Abstract (Originalsprache)
Background
The sudden onset of the SARS-Cov-2 (COVID-19) pandemic disrupted access to in-person nutrition consultation and prompted the rapid adoption of telehealth by dietitians.
Objective
This study investigates the use of telehealth among Lebanese Licensed Dietitians (LDs) during COVID-19, in the absence of national telehealth practical guidelines (TPG), and offers insights into its application amid overlapping crises including a pandemic, economic crisis, and infrastructure disruption in Lebanon.
Design
A cross-sectional study conducted in March 2023, using an anonymous 44-question online survey, distributed via the Lebanese Order of Dietitians and social media platforms.
Participants
Ninety-four dietitians participated (98.9% female, mean(SD) age: 30.54(6.41) years); mean(SD) experience: 7.89(5.7) years). Most reported practicing clinical nutrition as their primary practice area (87.2%), primarily in weight management (84%). Main outcome: Measures included Dietitians’ experience with telehealth, tools used in remote consultations, perceived barriers and facilitators, and perspectives on future application. Statistical analyses: Descriptive analysis (counts, frequencies) were analyzed using SPSS version 28.
Results
Telehealth use rose from 48.4% before COVID-19 to 97.8% during it. Commonly used platforms included WhatsApp (90.3%), Zoom (72.0%), and e-mails (41.9%). Reported barriers included bad internet connection (74.2%), patients preferring face-to-face consultation (61.3%), and patients unfamiliar with emerging videoconferencing technologies (33.3%). Benefits included scheduling and time flexibility (83.9%), decrease in practice-related costs (77.4%), and compliance with social distancing measures (53.8%). Most respondents acknowledged that Telehealth is needed (78.5%) and applicable in the Lebanese context (64.6%) and called for telehealth trainings (78.5%) and national TPG development (74.2%).
Conclusion
This study recognizes the growing use of telehealth in Lebanon, underscoring the need for telehealth with national regulations and evidence-based guidelines. Despite limited infrastructure, LDs continued delivering care, emphasizing the urgency for secure and standardized frameworks to support ethical and sustainable digital health practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Abu Dhabi School, Abu Dhabi School of Management, Abu Dhabi, United Arab Emirates.
- Department of Nutrition and Food Science, School of Arts and Sciences, Lebanese American University, Byblos, Lebanon.
- INSPECT-LB (Institut National de Santé Publique, d'Épidémiologie Clinique et de Toxicologie-Liban), Beirut, Lebanon.
ORCID-Profile: Maya Assaad, Rana Rizk
Zitieren
APA
Assaad, M., Chamma, N., Mateev, M., & Rizk, R. (2026). Telehealth during and beyond the COVID-19 Pandemic: Evidence from licensed dietitians in an emerging economy. PLOS One. https://doi.org/10.1371/journal.pone.0311330
Vancouver
Assaad M, Chamma N, Mateev M, Rizk R. Telehealth during and beyond the COVID-19 Pandemic: Evidence from licensed dietitians in an emerging economy. PLOS One. 2026. doi:10.1371/journal.pone.0311330
BibTeX
@article{Assaad2026,
author = {Assaad, Maya and Chamma, Nour and Mateev, Miroslav and Rizk, Rana},
title = {Telehealth during and beyond the COVID-19 Pandemic: Evidence from licensed dietitians in an emerging economy},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0311330}
}
EUVIMED